An Extension Study for Patients Previously Treated With ARQ 501

An Extension Study for Patients Previously Treated With ARQ 501

To provide ongoing treatment with ARQ 501 for patients who have benefited from prior treatment with ARQ 501

Inclusion Criteria:

• Signed written informed consent
• Has previous participated in a clinical trial with ARQ 501 and is eligible for continued treatment

Exclusion Criteria:

• Have not received previous treatment with ARQ 501 under a treatment protocol
• Uncontrolled intercurrent illness, uncontrolled infection or psychiatric illness/social situations that would limit compliance with study requirements